Fulcrum Therapeutics, Inc.
FULC
$7.63
-$0.02-0.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.65M | 214.11M | 226.60M | 241.02M | 257.23M |
| Total Receivables | 934.00K | 1.33M | 2.54M | 3.34M | 5.23M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.28M | 3.93M | 3.41M | 5.56M | 5.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 205.86M | 219.37M | 232.56M | 249.92M | 267.49M |
|
|
|||||
| Total Current Assets | 205.86M | 219.37M | 232.56M | 249.92M | 267.49M |
| Net Property, Plant & Equipment | 7.79M | 8.25M | 8.88M | 9.58M | 10.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.21M | 1.22M | 1.21M | 1.21M | 1.28M |
| Total Assets | 214.86M | 228.84M | 242.65M | 260.72M | 279.01M |
|
|
|||||
| Total Accounts Payable | 2.86M | 1.75M | 1.51M | 1.16M | 4.04M |
| Total Accrued Expenses | 6.19M | 4.77M | 3.91M | 7.23M | 7.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.35M | 2.29M | 2.24M | 2.19M | 2.13M |
| Total Finance Division Other Current Liabilities | 236.00K | 173.00K | 441.00K | 463.00K | 400.00K |
| Total Other Current Liabilities | 236.00K | 173.00K | 441.00K | 463.00K | 400.00K |
| Total Current Liabilities | 11.63M | 8.99M | 8.10M | 11.04M | 14.51M |
|
|
|||||
| Total Current Liabilities | 11.63M | 8.99M | 8.10M | 11.04M | 14.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.66M | 5.28M | 5.87M | 6.44M | 7.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 197.00K | 197.00K | 197.00K | 197.00K | 197.00K |
| Total Liabilities | 16.49M | 14.46M | 14.16M | 17.68M | 21.72M |
|
|
|||||
| Common Stock & APIC | 772.07M | 768.65M | 765.47M | 762.30M | 759.74M |
| Retained Earnings | -573.94M | -554.35M | -537.05M | -519.40M | -502.83M |
| Treasury Stock & Other | 241.00K | 82.00K | 70.00K | 130.00K | 379.00K |
| Total Common Equity | 198.37M | 214.38M | 228.49M | 243.03M | 257.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 198.37M | 214.38M | 228.49M | 243.03M | 257.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 198.37M | 214.38M | 228.49M | 243.03M | 257.29M |
|
|
|||||